GlassScriptPhysician profile
Andrew D Krouner
NPI 1740294255
$2,153.92
in general payments reported to CMS, 2019-2025
18 companies · $199 in 2025
The $199 reported for 2025 was less than what a typical Ophthalmology provider received nationally (typical 2025 total: $384).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $265 · 2020: $196 · 2021: $247 · 2022: $391 · 2023: $257 · 2024: $600 · 2025: $199.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,056.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,055.67 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novartis Pharmaceuticals Corporation | $381.25 | 2019-2023 | |
| Astellas Pharma US INC | $291.08 | 2024-2025 | Izervay |
| Oyster Point Pharma, INC. | $282.48 | 2022-2024 | Tyrvaya, Ryzumvi |
| Sun Pharmaceutical Industries INC. | $220.86 | 2019-2025 | |
| Alcon Vision LLC | $194.96 | 2021-2025 | Rocklatan, Eysuvis, Clareon |
| Abbvie INC. | $116.52 | 2022-2025 | |
| Mallinckrodt Enterprises LLC | $106.01 | 2019 | |
| Regeneron Healthcare Solutions, INC. | $99.94 | 2019-2021 | |
| Bausch & Lomb Americas INC. | $91.64 | 2022-2025 | Xiidra, Miebo, Vyzulta |
| Bausch & Lomb, A Division of Bausch Health US, LLC | $76.43 | 2019-2021 | |
| Mallinckrodt Hospital Products INC. | $73.39 | 2021-2022 | |
| Tarsus Pharmaceuticals, INC. | $57.17 | 2024-2025 | Xdemvy |
| Kala Pharmaceuticals, INC. | $39.71 | 2020-2021 | |
| Biotissue Holdings INC. | $38.20 | 2019-2021 | |
| Alimera Sciences, INC. | $26.13 | 2022 |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Ocular Therapeutix, INC. | $19.81 | 2020 | |
| Shire North American Group INC | $19.21 | 2019 | |
| Lensar, INC. | $19.13 | 2024 | Lensar Laser System |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Andrew Krouner listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.